UNVERIFIEDSingle SourceOcugen posts midphase gene therapy data, charting course for rivalry with Apellis, Astellas - Fierce BiotechGoogle News|1/15/2026
UNVERIFIEDSingle SourceAll the meetings, none of the megadeals: Is JPM's purpose evolving? - Fierce BiotechGoogle News|1/15/2026